key: cord-0918170-s41hgw91
authors: Gurung, Arun Bahadur; Ali, Mohammad Ajmal; Lee, Joongku; Farah, Mohammad Abul; Al-Anazi, Khalid Mashay
title: Identification of potential SARS-CoV-2 entry inhibitors by targeting the interface region between the spike RBD and human ACE2
date: 2020-12-21
journal: J Infect Public Health
DOI: 10.1016/j.jiph.2020.12.014
sha: 91a1b034c5fc22c8edd0a52694e6cebecceb558a
doc_id: 918170
cord_uid: s41hgw91

Coronavirus disease 2019 (COVID-19) is a fatal infectious disease caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). The virus infection is initiated upon recognition and binding of the spike (S) protein receptor-binding domain (RBD) to the host cell surface receptor, angiotensin-converting enzyme 2 (ACE2). Blocking the interaction between S protein and ACE2 receptor is a novel approach to prevent the viral entry into the host cell. The present study is aimed at the identification of small molecules which can disrupt the interaction between SARS-CoV-2 S protein and human ACE2 receptor by binding to the interface region. A chemical library consisting of 1,36,191 molecules were screened for drug-like compounds based on Lipinski’s rule of five, Verber’s rule and in silico toxicity parameters. The filtered drug-like molecules were next subjected to molecular docking in the interface region of RBD. The best three hits viz; ZINC64023823, ZINC33039472 and ZINC00991597 were further taken for molecular dynamics (MD) simulation studies and binding free energy evaluations using Molecular mechanics-Poisson–Boltzmann surface area (MM-PBSA) and Molecular mechanics-Generalized Born surface area (MM-GBSA). The protein-ligand complexes showed stable trajectories throughout the simulation time. ZINC33039472 exhibited binding free energy value lower as compared to the control (emodin) with a higher contribution by gas-phase energy and van der Waals energy to the total binding free energy. Thus, ZINC33039472 is identified to be a promising interfacial binding molecule which can inhibit the interaction between the viral S protein and human ACE2 receptor which would consequently help in the management of the disease.

headache, and pneumonia [2, 3] . Two other highly pathogenic human coronaviruses have been previously reported viz; the severe acute respiratory syndrome coronavirus (SARS-

Compared to the previous outbreaks from these two viruses, SARS-CoV-2 has a low mortality rate which ranges between 3 to 5% [1] . Phylogenetic studies have shown that SARS-CoV-2 is a new member within betacoronavirus genus which includes MERS-CoV, SARS-CoV, bat SARS-related coronaviruses (SARSr-CoV) etc. [4] . The closest relative of the SARS-CoV-2 is most likely to be Bat coronavirus RaTG13 which shows a similarity of 93.1% sequence identity in the spike (S) gene [5] . At present, there are no effective prophylactics or therapeutics available for the treatment of COVID-19 and as of May 5, 2020, there has been a total of 3 489 053 confirmed cases and 241 559 confirmed death reports [6] .

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a single positive-strand RNA enveloped virus with a genome size of 29.9 kb [7] . There are four structural proteins present in coronavirus viz; spike (S), envelope (E), membrane (M), and nucleocapsid (N) proteins [3] . Out of these, S protein, a type I transmembrane glycoprotein mediates key functions such as viral attachment, fusion and entry [8] . The first step in the viral infection cycle is the viral entry into the host cell which is mediated by binding of the S protein receptor-binding domain (RBD) to the host cell surface receptor which is angiotensinconverting enzyme 2 (ACE2) receptor in SARS-CoV and dipeptidyl peptidase 4 (DPP4) in case of MERS-CoV [9, 10] . Similarly, ACE2 also serves as a receptor for SARS-CoV-2 S protein. The RBD (residues 318-510) in the spike S1 subunit (residues 17-680) mediates the binding of the virus to the host cell surface receptor and the transmembrane S2 subunit (residues 681-1195) allows the fusion between the virus and the host cell membrane [11, 12] .

Because of its significant role in viral entry into the host cell, S protein has emerged as an important therapeutic target for the development of antibodies, vaccines and entry inhibitors [6] .

Protein-protein interactions (PPIs) play an important role in regulating various cellular processes as well as drive the pathogenesis in many human diseases such as neurodegenerative diseases, cervical cancer, bacterial infection and leukaemia etc. [13] .

Computational study of protein-protein interactions plays a significant role in the drug discovery process which can provide useful insights into the biochemical nature of the protein-protein interface, mutations affecting the binding interface and designing small J o u r n a l P r e -p r o o f molecules which can regulate the pathological cellular processes [14] . This rational approach has been widely used in designing of many PPI modulators which can be categorized into three different types-a) orthosteric inhibitor b) allosteric inhibitor and c) interfacial inhibitor [15] . The orthosteric inhibitors bind to the protein target preferentially at regions which are normally used by other interacting protein partners for binding and therefore, disrupt the formation of functional biological complexes. A typical example of orthosteric inhibitor is MI-2-2 which binds to menin with nanomolar binding affinity and disrupts the proteinprotein interaction between menin and MLL in mixed lineage leukemia (MLL) leukaemia cells [16] . Whereas allosteric inhibitors bind to sites distinct from the protein-protein interface region and cause a conformational change in the target protein and thereby destabilizing the protein-protein complex. BRaf inhibitor, PLX4032 is an example of an allosteric inhibitor that inhibits BRaf-CRaf heterodimerization and activation [17] . The interfacial inhibitors are small molecules which bind to a pocket at the protein-protein interface to form a ternary complex and render the protein ineffective by locking the complex into a non-functional state. An example in this category include the interfacial binding inhibitor BFA binds at the protein-protein interface of ARF1-GDP-Sec7 complex and inhibits conformational changes in ARF1 necessary for Sec7 to displace the GDP molecule [18] . Protein-protein interaction study between human ACE2 and SARS-CoV-2 S protein can be used to design interface binding inhibitors which can disrupt the protein-protein interaction and inhibit the attachment and entry of the virus into the host cell. In this study, we have screened a chemical compound library to screen novel drug-like molecules which can effectively bind to the interface region between RBD of SARS-CoV-2 S protein and human ACE2 which will help in blocking the viral attachment and entry into the host cell.

The three dimensional X-ray crystal structure of SARS-CoV-2 spike receptor-binding domain (RBD) bound with human ACE2 (PDB ID: 6M0J) and the crystal structure of SARS-CoV spike RBD complexed with human ACE2 (PDB ID: 2AJF) were retrieved from Protein Data Bank (PDB) (http://www.rcsb.org/) at a resolution of 2.45 Å and 2.90 Å respectively.

J o u r n a l P r e -p r o o f

The protein-protein interface statistics including interface area, interface residues and residue interactions across the interface (salt bridges, disulphide bonds, hydrogen bonds and nonbonded contacts) were determined using PDBsum program [19] . The hotspot residues in protein-protein interfaces were calculated using alanine scanning mutagenesis program of DrugScorePPI webserver (Kruger & Gohlke, 2010).

The pairwise sequence alignment between SARS-CoV-2 spike RBD and SARS-CoV spike RBD was carried out using the CLUSTAL W program [21] . The root mean square deviation (RMSD) between structures of SARS-CoV-2 spike RBD and SARS-CoV spike RBD was calculated using UCSF Chimera [22] .

A random set of 1,36,191 chemical compounds were retrieved from the ZINC database [23] .

The chemical structures were downloaded and saved in SDF format for the virtual screening process.

The chemical library was subjected to virtual screening procedure based on selected drug-like filters such as Veber's rule [24] , Lipinski's rule of five (ROF) [25] and in silico toxicity parameters such as mutagenicity, tumorigenicity, irritancy and reproductive effects. The physicochemical properties of the compounds were calculated using the OSIRIS DataWarrior program version 5.0 [26] .

Virtual screening of potential hits binding to SARS-CoV-2 spike RBD was performed using ArgusLab docking program version 4.0 [27] . A grid box of size 40×40×40 Å with a grid resolution of 0.4 was placed at the centre around the interface residues. The other parameters include AScore as scoring function and the DockEngine was set to exhaustive search. The top J o u r n a l P r e -p r o o f 100 hits were docked within the interface region using AutoDock Vina program which utilizes sophisticated gradient optimization method [28] . The target protein was prepared by removing the heteroatoms such as ions, water molecules and cocrystal ligands and the addition of polar hydrogen atoms and Kollman charges. Similarly, the chemical compounds were prepared by adding hydrogen atoms, Gasteiger charges and optimally defining the 

The molecular dynamics of the spike-ligand docked complexes were performed using AMBER16 program available on Ligand and Receptor Molecular Dynamics (LARMD) (http://chemyang.ccnu.edu.cn/ccb/server/LARMD/). The interactional binding mode (Int_mod) was chosen for 4 ns MD simulation in an explicit water model [30] . The steps involved in the MD simulations consist of a) assignment of bcc charges to the ligand atoms using the antechamber module of the AMBER16 program [31] b) generation of the coordinate and topology files of the complex using Tleap module of the AMBER16 program c)The force fields selected for amino acid residues and ligands include the AMBER ff14SB force field [32] and General AMBER Force Field (GAFF) [33, 34] respectively d) Addition of counter ions (Na + and Cl -) to the system e) the systems were explicitly solvated in an octahedral box of TIP3P waters [35] f) energy minimization with 2000 steps steepest descent method and 3000 steps conjugated gradient method using sander module in the AMBER16 program [36] g) the systems were gradually heated by raising the temperature from 10 to 300 K for 30 ps. All the atoms were relaxed using periodic boundary conditions at a temperature of 300 K and pressure of 1 atm.

The geometric properties of the systems such as root mean square deviation (RMSD), radius of gyration (Rg) and fraction of native contacts (Q) values were analysed using the Cpptraj J o u r n a l P r e -p r o o f module in the AMBER16 program module [37] . R package was used to analyse the RMSD distribution of protein and ligand in a histogram representation. The non-native contacts were calculated using MDTraj was and Bio3d was used to study the principal component analysis PCA and residue cross-correlation [38] .

The binding free energy (∆ ) was calculated using the following equation 1

Where ∆ is the binding energy, ∆ is the solvation entropy and ∆ is the conformational entropy. While the enthalpy was calculated using the Molecular mechanics

Poisson-Boltzmann surface area (MM-PBSA) or molecular mechanics generalized Born surface area (MM-GBSA) method [39] , entropy was derived using an empirical method ( [40, 41] .

The human angiotensin-converting enzyme 2 (ACE2) and SARS-CoV-2 spike receptorbinding domain (RBD) and human ACE2 and SARS-CoV spike RBD were analysed for their interface regions and key residues contributing to the binding recognition between the interacting protein partners. The interface region between human ACE2 and SARS-CoV spike RBD complex was investigated and there are nineteen interface residues (Gln24, Thr27,

Asn330, Lys353, Gly354, Asp355 and Arg357) of ACE2 and fifteen residues of spike RBD (Arg426, Tyr436, Tyr440, Tyr442, Leu472, Asn473, Tyr475, Asn479, Gly482, Tyr484, Thr486, Thr487, Gly488, Ile489 and Tyr491) forming an interface area of 832 Å 2 and 872 Å 2 respectively (Figure 1 A) . The complex is stabilised by 1 salt bridge, 9 hydrogen bonds and 94 non-bonded contacts. Further, alanine scanning mutagenesis of the interface residues was carried out to determine residues (hotspots) contributing more to the binding between the two J o u r n a l P r e -p r o o f interacting proteins. Hot spots are residues which contributes a significant increase in the binding free energy of at least 2.0 kcal/mol when replaced with alanine [42] . Both ACE2 receptor and SARS-CoV spike RBD possess two hotspot residues in their interface regions which are Asp38 and Tyr41 in ACE2 and Tyr475 and Tyr491 in spike RBD (Suppl. Figure 1 A (Figure 1 B) . The protein-protein complex between ACE2 and SARS-CoV-2 spike RBD were stabilized by 1 salt bridge, 9 hydrogen bonds and 101 non-bonded contacts. Three hotspot residues (Asp38, Tyr41 and Tyr83) were identified in ACE2 and two hot spot residues (Tyr489 and Tyr505) in SARS-CoV-2 spike RBD (Suppl. Figure 1 B) . The interface statistics differences in terms of the number of interface residues and non-bonded contacts between the two protein-protein complexes may plausibly explain the differential nature of binding of SARS-CoV-2 and SARS-CoV spike protein to ACE2 receptor. It has been revealed from an earlier study that ACE2 binds to SARS-CoV-2 ectodomain with approximately 15 nM affinity which is around 10-20 fold higher than its binding to SARS-CoV [43] .

The primary sequence alignment of SARS-CoV-2 and SARS-CoV spike RBD domains show a sequence similarity of 72.38% and out of the five critical residues (Tyr442, Leu472, Asn479, Thr487 and Tyr491) at the SARS-CoV spike RBD and ACE2 interface, only Tyr491 is conserved (Figure 2A) The results corroborates with the previous studies by Xie and Chen, 2020. It is worth mentioning here that Asn479 and Asn487 are two important residues in RBD which determine SARS progression and tropism, and their mutations may increase animal-to-human or human-to-human transmission [12] . Further, their structural kcal/mol) which possessed higher binding affinity to SARS-CoV-2 spike RBD as compared to emodin (-6.1 kcal/mol) ( Table 1) . The drug-like properties of the top 3 compounds along with the control are enumerated in Table 2 The interaction between ZINC64023823 and spike protein is strengthened by three hydrogen bonds with residues Asn437, Asn440 and Gln506 and hydrophobic interactions with eight residues including Leu441, Arg509, Ala344, Asn343, Phe374, Ser373, Trp436 and Val503 ( Figure 3A) . Whereas, the second lead molecule ZINC33039472 forms one hydrogen bond with Ty453 within the binding cleft of J o u r n a l P r e -p r o o f spike protein and the interaction is further reinforced through hydrophobic interactions with seven residues including Arg403, Tyr495, Tyr505, Asn501, Gly502, Gly496 and Gln498

( Figure 3B) . The third lead molecule ZINC00991597 interacts with the spike protein by establishing one hydrogen bond with Gly496 and hydrophobic interactions contributed by seven residues including Tyr453, Ser494, Asn501, Gly502, Tyr505, Arg403 and Tyr495

( Figure 3C) . Interestingly, the control emodin establishes four hydrogen bonds with residues-Arg346, Tyr351, Asn354 and Asn450 and hydrophobic interactions via five residues such as Ala348, Phe347, Ala352, Ser349 and Leu452 (Figure 3D ).

The binding modes of the best three lead molecules-ZINC64023823, ZINC33039472 and Figure 2 ).

The Q gives an idea about conformational dynamics and the transition states of a protein with a folding free energy barrier [48] . 

The binding free energies of ZINC64023823 (ΔPB=-2.91 kcal/mol, ΔGB=-3.00 kcal/mol), ZINC33039472 (ΔPB=-9.08 kcal/mol, ΔGB=-11.73 kcal/mol), ZINC00991597 (ΔPB=-2.53 kcal/mol, ΔGB=-3.67 kcal/mol) and the control (emodin) (ΔPB=-6.02 kcal/mol, ΔGB=-6.41 kcal/mol) were determined using Molecular mechanics Poisson-Boltzmann surface area (MM-PBSA) and molecular mechanics generalized Born surface area (MM-GBSA) methods.

( Table 3) . Out of the three lead compounds, ZINC33039472 has a binding free energy value higher than the control with major contribution by Gas phase energy (-33.89±3.56 kcal/mol) and van der Waals energy (-30.20±3.89 kcal/mol). The top ten residues contributing towards the binding interaction between ZINC33039472 and spike protein include Arg403 (-2. kcal/mol) and Tyr451 (-0.04 kcal/mol) contribute significantly to the total binding energy (Figure 6 B) . In both the cases, the top ten residues have more contribution of gas phase energy and van der Waals energy to the total binding energy as compared to the electrostatic energy contribution.

The high mortality rates of COVID-19 and lack of effective approved therapeutics remains a global concern. COVID-19 is caused by a positive-stranded RNA virus known as severe 

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Subunit vaccines against emerging pathogenic human coronaviruses

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine

The hallmarks of COVID-19 disease

Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors

Angiotensinconverting enzyme 2 is a functional receptor for the SARS coronavirus

Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC

Cleavage of spike protein of SARS coronavirus by protease factor Xa is associated with viral infectivity

Structure of SARS coronavirus spike receptorbinding domain complexed with receptor

Protein--protein interactions in human disease

Protein interactions and disease

Binding of small molecules at interface of protein--protein complex--A newer approach to rational drug design

Structural insights into inhibition of the bivalent menin-MLL interaction by small molecules in leukemia

RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth

Crystal structure of ARF1• Sec7 complexed with Brefeldin A and its implications for the guanine nucleotide exchange mechanism

PDBsum: Structural summaries of PDB entries

DrugScorePPI webserver: fast and accurate in silico alanine scanning for scoring protein--protein interactions

CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, positionspecific gap penalties and weight matrix choice

UCSF Chimera--a visualization system for exploratory research and analysis

ZINC--a free database of commercially available compounds for virtual screening

Molecular properties that influence the oral bioavailability of drug candidates

Lead-and drug-like compounds: the rule-of-five revolution

DataWarrior: an open-source program for chemistry aware data visualization and analysis

Molecular docking using ArgusLab, an efficient shape-based search algorithm and the AScore scoring function

AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading

LigPlot+: multiple ligand-protein interaction diagrams for drug discovery

LARMD: integration of bioinformatic resources to profile ligand-driven protein dynamics with a case on the activation of estrogen receptor

Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation

ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB

A fast QM/MM (quantum mechanical/molecular mechanical) approach to calculate nuclear magnetic resonance chemical shifts for macromolecules

Development and testing of a general amber force field

A modified TIP3P water potential for simulation with Ewald summation

The Amber biomolecular simulation programs

CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data

Bio3d: an R the comparative analysis of protein structures

Assessing the performance of the MM/PBSA and MM/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations

Understanding the mechanism of drug resistance due to a codon deletion in protoporphyrinogen oxidase through computational modeling

Modeling the catalysis of anti-cocaine catalytic antibody: competing reaction pathways and free energy barriers

ASEdb: a database of alanine mutations and their effects on the free energy of binding in protein interactions

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Insight into 2019 novel coronavirus-an updated intrim review and lessons from SARS-CoV and MERS-CoV

Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction

Significance of root-mean-square deviation in comparing three-dimensional structures of globular proteins

Radius of gyration as an indicator of protein structure compactness

Native contacts determine protein folding mechanisms in atomistic simulations

ZINC64023823 3-(2H-indol-3-yl)-N

-phenylthiazol-4-yl)methylene]-2-(2-pyridylmethyl)isoquinoline-1

ZINC00991597 2-(3,4-dimethoxyphenyl)-N'-(2-naphthylsulfonyl)acetohydrazide

Emodin (CID3220) 1,3,8-trihydroxy-6-methylanthracene-9

The authors would like to extend their sincere appreciation to the Researchers Supporting 

The authors report no conflicts of interest in this work.